Download video

Conversations in Advanced NSCLC - Optimizing use of ADCs

25 views

Practice Point Communications

10 months ago

Conversations in Advanced NSCLC - Optimizing use of ADCs

Conversations in Advanced NSCLC - Optimizing use of ADCs

Conversations in Advanced NSCLC - Optimizing use of ADCs
17:04
Conversations in Advanced NSCLC - Optimizing use of ADCs
by Practice Point Communications
Conversations in Advanced NSCLC - Impact of ADCs
12:05
Conversations in Advanced NSCLC - Impact of ADCs
by Practice Point Communications
Conversations in Advanced NSCLC - Rationale for ADCs
15:37
Conversations in Advanced NSCLC - Rationale for ADCs
by Practice Point Communications
Conversations in Advanced NSCLC: Rationale and Utility of TROP2 Antibody-Drug Conjugates Based on...
17:47
Conversations in Advanced NSCLC: Rationale and Utility of TROP2 Antibody-Drug Conjugates Based on...
by Practice Point Communications
Optimizing Advanced NSCLC Biomarker Testing, Treatment and Management Session 1
1:20:16
Optimizing Advanced NSCLC Biomarker Testing, Treatment and Management Session 1
by ASCP
Emerging second-line treatment approaches in advanced NSCLC: The role of ADCs
34:17
Emerging second-line treatment approaches in advanced NSCLC: The role of ADCs
by Touch Medical Media
Conversations in Advanced NSCLC: Rationale and Utility of TROP2 Antibody-Drug Conjugates Based on...
12:48
Conversations in Advanced NSCLC: Rationale and Utility of TROP2 Antibody-Drug Conjugates Based on...
by Practice Point Communications
Conversations in Advanced NSCLC: Rationale and Utility of TROP2 Antibody-Drug Conjugates Based on...
16:20
Conversations in Advanced NSCLC: Rationale and Utility of TROP2 Antibody-Drug Conjugates Based on...
by Practice Point Communications
Antibody-drug conjugates (ADCs) in NSCLC
1:33
Antibody-drug conjugates (ADCs) in NSCLC
by VJOncology
Challenges in development and clinical use of ADCs for lung cancer
1:35
Challenges in development and clinical use of ADCs for lung cancer
by VJOncology
Are You Prepared for the New Wave of ADCs in NSCLC? Targeting HER2, HER3, TROP2, and Others
56:23
Are You Prepared for the New Wave of ADCs in NSCLC? Targeting HER2, HER3, TROP2, and Others
by PeerView Oncology
ADCs in lung cancer treatment
1:24
ADCs in lung cancer treatment
by VJOncology
Answers to Key Questions About Antibody–Drug Conjugates in NSCLC
1:00:29
Answers to Key Questions About Antibody–Drug Conjugates in NSCLC
by PeerView Oncology
The Role of Antibody Drug Conjugates in Advanced NSCLC: Guidance for Today \& the Path Forward
1:44:30
The Role of Antibody Drug Conjugates in Advanced NSCLC: Guidance for Today \& the Path Forward
by CME Outfitters
Emerging role of ADCs in EGFR-mutated non-small cell lung cancer
1:13
Emerging role of ADCs in EGFR-mutated non-small cell lung cancer
by VJOncology
Developments in ADCs for NSCLC
1:59
Developments in ADCs for NSCLC
by VJOncology
The Role of Antibody Drug Conjugates in Advanced Non-Small Cell Lung Cancer
1:26:11
The Role of Antibody Drug Conjugates in Advanced Non-Small Cell Lung Cancer
by CME Outfitters
HERTHENA-Lung02: exploring patritumab deruxtecan in NSCLC
0:41
HERTHENA-Lung02: exploring patritumab deruxtecan in NSCLC
by VJOncology
Amplifying the ADC Advantage: ADCs as the Next Frontier in Precision Lung Cancer Care
1:37:33
Amplifying the ADC Advantage: ADCs as the Next Frontier in Precision Lung Cancer Care
by PeerView Oncology